ESPERION THERAPEUTICS INC NE's ticker is ESPR and the CUSIP is 29664W105. A total of 141 filers reported holding ESPERION THERAPEUTICS INC NE in Q3 2021. The put-call ratio across all filers is 1.72 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $12,000 | -42.9% | 976 | 0.0% | 0.00% | – |
| Q2 2021 | $21,000 | -22.2% | 976 | 0.0% | 0.00% | – |
| Q1 2021 | $27,000 | -25.0% | 976 | -28.6% | 0.00% | – |
| Q4 2020 | $36,000 | -29.4% | 1,366 | 0.0% | 0.00% | – |
| Q3 2020 | $51,000 | -27.1% | 1,366 | 0.0% | 0.00% | – |
| Q2 2020 | $70,000 | -89.1% | 1,366 | -91.7% | 0.00% | -100.0% |
| Q2 2018 | $642,000 | -82.9% | 16,395 | -68.3% | 0.00% | -85.7% |
| Q1 2018 | $3,744,000 | +174.5% | 51,759 | +149.9% | 0.01% | +250.0% |
| Q4 2017 | $1,364,000 | +16.7% | 20,711 | -11.2% | 0.00% | 0.0% |
| Q3 2017 | $1,169,000 | -1.1% | 23,329 | -8.7% | 0.00% | 0.0% |
| Q2 2017 | $1,182,000 | – | 25,549 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Meditor Group Ltd | 3,791,300 | $3,715,474 | 4.82% |
| Two Seas Capital LP | 7,672,170 | $7,518,727 | 1.51% |
| Parkman Healthcare Partners LLC | 1,997,071 | $1,957,130 | 0.36% |
| Monaco Asset Management SAM | 1,171,779 | $1,148,343 | 0.34% |
| TANG CAPITAL MANAGEMENT LLC | 1,850,000 | $1,813,000 | 0.26% |
| Ikarian Capital, LLC | 1,737,636 | $1,702,883 | 0.20% |
| PLATINUM INVESTMENT MANAGEMENT LTD | 3,189,517 | $3,125,727 | 0.12% |
| GSA CAPITAL PARTNERS LLP | 1,116,655 | $1,094 | 0.09% |
| XTX Topco Ltd | 519,129 | $508,746 | 0.09% |
| JACOB ASSET MANAGEMENT OF NEW YORK LLC | 60,000 | $58,800 | 0.08% |